← Back
$AVTX All transactions

Avalo Therapeutics, Inc.

M

$ Value

Shares

3,166

Price

Filed

Mar 31

Insider

Name

Chan Mitchell

Title

CIK

0001789335

Roles

Director

Transaction Details

Transaction Date

2026-03-28

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

6,333

Footnotes

Restricted stock units convert into common stock on a one-for-one basis. | On August 13, 2024, the Reporting Person was granted 9,500 restricted stock units, vesting 1/3 on March 28, 2025, March 28, 2026, and March 28, 2027, subject to the Reporting Person's continued service on such vesting date.

Filing Info

Accession No.

0001789335-26-000004

Form Type

4

Issuer CIK

0001534120

Chan Mitchell's History

Date Ticker Type Value
2026-03-28 AVTX M
2026-03-28 AVTX M $0
2025-09-01 RGNX F $44K
2025-06-17 AVTX A $0

Other Insiders at AVTX (90d)

Insider Bought Sold Last
KAPLAN GILLA 2026-03-28
NEIL GARRY ARTHUR
Chief Executive Officer
2026-03-28
Lind Kevin Robert 2026-03-31
Jain Rita 2026-03-31
Chan Mitchell 2026-03-28
Sullivan Christopher Ryan
Chief Financial Officer
$271K 2026-04-02
KANTOFF AARON 2026-03-28
Doyle Mittie
Chief Medical Officer
$82K 2026-04-06
Goldman Jonathan 2026-03-28
Truex Samantha 2026-03-28